Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Therapeutic exercises and its impact on fatigue, physical endurance and exercise tolerance in late-onset muscular dystrophies: a systematic review & meta-analysis.

Created on 09 Jul 2026

Authors

Farah Bazigha, Sarah Parveen, Chhavi Arora Sehgal, Syed Naznin Fatma, Dilshad Manzar, Majumi M Noohu

Published in

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. Volume 47. Issue 8. Jul 09, 2026. Epub Jul 09, 2026.

Abstract

Muscular dystrophy (MD) is a progressive neuromuscular disorder characterized by muscle degeneration, leading to fatigue, reduced endurance, and impaired functional capacity. Evidence regarding the role of therapeutic exercises in late-onset muscular dystrophies (LOMD) remains limited and inconclusive.
A systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted in accordance with PRISMA guidelines. Electronic databases including MEDLINE, Scopus, and Web of Science were searched from inception to September 2025. Eligible studies evaluated the effects of therapeutic exercises on fatigue, exercise tolerance, and aerobic capacity in individuals with LOMD. Data extraction and risk of bias assessment were performed independently by two reviewers. Meta-analysis was conducted using a random-effects model.
Eight RCTs involving 501 participants were included. Meta-analysis demonstrated small, statistically non-significant effects of therapeutic exercises on fatigue (SMD = -0.20; 95% CI: -0.72 to 0.33; p = 0.46), exercise tolerance (SMD = 0.16, 95% CI: -0.06 to 0.38; p = 0.15), and aerobic power (SMD = 0.12; 95% CI: -0.24 to 0.48; p = 0.51). Heterogeneity ranged from low to high across outcomes.
Therapeutic exercises appears to be a safe adjunct intervention and may provide small, although statistically non-significant, improvements in fatigue, exercise tolerance, and aerobic capacity in individuals with LOMD. While the findings suggest potential clinical benefits, the limited number of high-quality trials and heterogeneity warrant cautious interpretation. Further large-scale, well-designed RCTs are required to establish definitive evidence.

PMID:
42420535
Bibliographic data and abstract were imported from PubMed on 09 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 2
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement